首页> 外文学位 >Modulation of gene expression in chemical carcinogenesis: Analysis of aflatoxin B(1) induced gene expression in primary human hepatocytes.
【24h】

Modulation of gene expression in chemical carcinogenesis: Analysis of aflatoxin B(1) induced gene expression in primary human hepatocytes.

机译:基因表达在化学致癌作用中的调节:黄曲霉毒素B(1)诱导的人类原代肝细胞中基因表达的分析。

获取原文
获取原文并翻译 | 示例

摘要

Hepatotoxicity is the most common adverse event of newly marketed drugs. Despite extensive pre-clinical toxicity testing and review by the Food and Drug Administration (FDA), it is difficult to predict human hepatotoxicity from testing in other species. In addition, there are insufficient models to identify drugs and chemicals that are potentially non-genotoxic carcinogens in humans. Therefore, it would be advantageous to develop in vitro human assays to evaluate drug responses in humans.; Any drug or chemically induced endpoint is likely to be associated with some alteration in the gene expression of the exposed cell, therefore an analysis of genes that are responsive to known hepatotoxins or hepatocarcinogens could be used to develop an in vitro screen that is predictive of toxicity or carcinogenicity in new drugs and chemicals.; In this study, primary human hepatocytes and HepG2 cells were evaluated as in vitro models of human hepatoxicity by comparing the variability of basal gene expression in primary hepatocytes from different donors and between human hepatocytes and HepG2 cells. The GDA 1.3 human DNA filter array (GenomeSystems) was used for gene expression analysis. The effects of plating matrix, medium and time in culture on basal levels of stress gene expression in primary human hepatocytes were investigated using the Atlas™ stress filter array. To identify chemically responsive genes, HepG2 cells and primary human hepatocytes from five donors were exposed to sub-toxic doses of two hepatotoxic chemicals, aflatoxin B1 (AFB1) or acetaminophen (APAP). RNA was isolated from each treatment group and used to prepare a 33P-radiolabeled cDNA probe that was hybridized to a GDA 1.3 human DNA filter array.; It was found that matrigel was the optimal culturing matrix for primary human hepatocytes. Primary human hepatocytes from different donors had variable basal gene expression patterns and responses to AFB1. HepG2 cells expressed a subset of genes not expressed in primary human hepatocytes. Fourteen genes were ATB1 responsive in at least two samples. Six of the genes were also responsive to APAP. These data can be used to develop novel mechanistic studies and to develop gene expression profiles for hepatotoxins and carcinogens.
机译:肝毒性是新上市药物最常见的不良事件。尽管进行了广泛的临床前毒性测试并获得了美国食品药品监督管理局(FDA)的审查,但很难通过其他物种的测试来预测人的肝毒性。此外,没有足够的模型来识别可能是人类非遗传毒性致癌物的药物和化学物质。因此,开发体外人体分析方法以评估人体药物反应将是有利的。任何药物或化学诱导的终点都可能与暴露细胞的基因表达发生某些变化有关,因此可以对对已知肝毒素或肝致癌物有反应的基因进行分析,以开发出体外可以预测新药和化学药品的毒性或致癌性的筛查;在这项研究中,通过比较不同供体的原代肝细胞以及人肝细胞与HepG2细胞之间基础基因表达的变异性,将原代人肝细胞和HepG2细胞评估为人肝毒性的“体外”模型。 GDA 1.3人类DNA过滤器阵列(GenomeSystems)用于基因表达分析。使用Atlas™应力过滤器阵列研究了培养基质,培养基和培养时间对原代人肝细胞中应力基因表达基础水平的影响。为了鉴定化学反应基因,将来自五个供体的HepG2细胞和原代人肝细胞暴露于亚毒性剂量的两种肝毒性化学药品中,黄曲霉毒素B 1 (AFB 1 )或对乙酰氨基酚(APAP)。从每个治疗组中分离出RNA,并用于制备 33 放射性标记的cDNA探针,该探针与GDA 1.3人DNA滤膜阵列杂交。发现基质胶是人原代肝细胞的最佳培养基质。来自不同供体的原代人肝细胞具有可变的基础基因表达模式和对AFB 1 的反应。 HepG2细胞表达了人类原代肝细胞中未表达的基因子集。至少有两个样本中有14个基因对ATB 1 有反应。六个基因也对APAP有反应。这些数据可用于开发新颖的机理研究,以及开发肝毒素和致癌物的基因表达谱。

著录项

  • 作者

    Harris, Angela Joyce.;

  • 作者单位

    University of Arkansas for Medical Sciences.;

  • 授予单位 University of Arkansas for Medical Sciences.;
  • 学科 Health Sciences Toxicology.; Biology Molecular.
  • 学位 Ph.D.
  • 年度 2001
  • 页码 138 p.
  • 总页数 138
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 毒物学(毒理学);分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号